KRT8 antibody
-
- Target See all KRT8 Antibodies
- KRT8 (Keratin 8 (KRT8))
-
Reactivity
- Human, Rat, Mouse
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This KRT8 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogen
- KLH conjugated Synthetic peptide corresponding to Mouse Cytokeratin 8
- Isotype
- IgG
- Top Product
- Discover our top product KRT8 Primary Antibody
-
-
- Application Notes
- WB 1:500-1:2000, IHC 1:200-1:800
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 430 μg/mL
- Buffer
- PBS with 0.02 % sodium azide, 1 % BSA and 50 % glycerol, pH 7.4
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- KRT8 (Keratin 8 (KRT8))
- Alternative Name
- CK-8 (KRT8 Products)
- Background
- Cytokeratin 8 (CK8) has a molecular weight of 52.5 KDa, which belongs to the HMW (high molecular weight) B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.
- Molecular Weight
-
Observed_MW: 54 kDa
Calculated_MW: 54 kDa
- UniProt
- P05787, P11679, Q10758
-